Hallie Kuhn
Patrimonio netto: 2 M $ in data 31/05/2026
Patrimonio netto: 2 M $ in data 31/05/2026
Hallie Kuhn currently works at Molecular Assemblies, Inc., as Director, Eclipse Bioinnovations, Inc., as Director from 2022, Alexandria Real Estate Equities, Inc., as Executive Vice President-Capital Markets from 2026, and Alexandria Venture Investments LLC, as Vice President of Science & Technology.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/04/2026 | 48.301 ( 0,03% ) | 2 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | Corporate Officer/Principal | 01/01/2026 |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Direttore/Membro del Consiglio | - |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Develops technologies platform for RNA medicines | Direttore/Membro del Consiglio | 15/03/2022 |
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture invests in companies located in the United States. The firm targets companies operating in disruptive life science, innovative medicine and technology. It provides financing for seed, early and growth stage capital requirements. | Investitore di Private Equity | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. Real Estate Investment TrustsFinance Operates as a real estate investment trust which leases life science, agri-tech, and advanced technology mega campuses | Finance |
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture invests in companies located in the United States. The firm targets companies operating in disruptive life science, innovative medicine and technology. It provides financing for seed, early and growth stage capital requirements. | Finance |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Health Technology |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Develops technologies platform for RNA medicines | Technology Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale